Stericycle Profits Rise Despite Revenue Declines
Stericycle reported stronger profitability in the third quarter despite experiencing slower top-line growth both year over year and sequentially. Seventeen acquisitions contributed toward an increase in revenue by 11.3% to $535 million in the quarter; however, consolidated internal growth of 6.5% was on the low end of Stericycle’s typical target range. In particular, domestic small quantity (SQ) revenue grew organically by 8%, and large quantity … Continue reading Stericycle Profits Rise Despite Revenue Declines
Maxim`s Results Propelled by Samsung Galaxy S4 Launch
Maxim Integrated reported solid fiscal third-quarter earnings on Thursday. The firm’s fourth-quarter revenue outlook was modestly lower than our expectations, but still point toward healthy analog chip demand from Samsung, and a recovery from a recent industry downturn. Maxim’s analog chip sales were $605 million, at the high end of the firm’s forecasted range of $580 million-$610 million put forth in January. Sales were flat, … Continue reading Maxim`s Results Propelled by Samsung Galaxy S4 Launch
Dentsply Continues to Face Strong Headwinds in Europe
Although Dentsply’s revenue growth continues to fall slightly short our expectations, management’s ability to offset the medical device tax combined with the integration of Astra Tech kept total earnings growth near analyst’s forecasts. Excluding precious metals, Dentsply’s revenue increased 3.4%, or 2.7% on a constant currency basis, which is slightly below last year’s internal growth but on par with the second quarter. While sales growth … Continue reading Dentsply Continues to Face Strong Headwinds in Europe
Low Coal Prices Drive Huaneng Earnings in Quarter
Huaneng Power International reported 2013 third-quarter earnings of $1.52 per ADR compared with $0.92 per ADR in 2012’s third quarter. The reported results included an asset impairment charge and loss on disposal of noncurrent assets that reduced reported earnings by roughly $0.24 per ADR. Low market coal prices continue to drive strong earnings. We are reaffirming our narrow moat and stable moat trend ratings and … Continue reading Low Coal Prices Drive Huaneng Earnings in Quarter
SVB Financial Posts 18% Increase in Revenue
SVB Financial Group’s first-quarter profits available to common investors rose 18% to $40.9 million, or $0.90 per diluted share, from $34.8 million, or $0.78 per diluted share, in the year-earlier first quarter. We are not changing our $55 per share fair value estimate or our narrow economic moat rating at this time. Noninterest expense rose 13% to $149 million. Noninterest income climbed 33% year over … Continue reading SVB Financial Posts 18% Increase in Revenue
Weak Hospital Spending Hurts Varian Medical Systems in Quarter
Varian Medical Systems reported fairly weak fiscal fourth-quarter results. The company’s performance continues to be affected by tightening U.S. radiology reimbursement for freestanding clinics and the generally weak hospital spending environment. Our narrow moat and positive moat trend ratings remain intact; we continue to believe Varian is well positioned to capitalize on its strong technological platform and produce strong results over the next decade. We’re … Continue reading Weak Hospital Spending Hurts Varian Medical Systems in Quarter